ABIVAX Société Anonyme Management
Management criteria checks 2/4
ABIVAX Société Anonyme's CEO is Marc M. de Garidel, appointed in May 2023, has a tenure of less than a year. total yearly compensation is €793.97K, comprised of 45.3% salary and 54.7% bonuses, including company stock and options. directly owns 0.061% of the company’s shares, worth €565.34K. The average tenure of the management team and the board of directors is 0.8 years and 5.2 years respectively.
Key information
Marc M. de Garidel
Chief executive officer
€794.0k
Total compensation
| CEO salary percentage | 45.3% |
| CEO tenure | less than a year |
| CEO ownership | 0.06% |
| Management average tenure | less than a year |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | €794k | €359k | -€148m |
Compensation vs Market: Marc M.'s total compensation ($USD849.35K) is below average for companies of similar size in the German market ($USD1.29M).
Compensation vs Earnings: Insufficient data to compare Marc M.'s compensation with company performance.
CEO
Marc M. de Garidel (65 yo)
less than a year
Tenure
€793,971
Compensation
Mr. Marc M. P. de Garidel, M.B.A., serves as Director of Claris Biotherapeutics, Inc. He serves as CEO & Interim Chair of Board at ABIVAX Société Anonyme since May 5, 2023. He has been the Chief Executive...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Interim Chair of Board | less than a year | €793.97k | 0.061% € 565.3k | |
| Founder & Director | no data | no data | 0.44% € 4.1m | |
| EVP, CFO & Board Secretary | 7.3yrs | no data | 0.00059% € 5.5k | |
| Chief Scientific Officer | less than a year | no data | 0.057% € 530.2k | |
| Senior Vice President of Investor Relations | less than a year | no data | no data | |
| Chief People Officer | less than a year | no data | no data | |
| Chief Business Officer | no data | no data | 0% € 0 | |
| Executive Vice President of Process Development & Manufacturing | less than a year | no data | no data | |
| Chief Medical Officer | 1.1yrs | no data | no data | |
| Chief Commercial Officer | less than a year | no data | no data | |
| VP & Global Head of Quality | less than a year | no data | no data |
0.8yrs
Average Tenure
56.5yo
Average Age
Experienced Management: 2X1's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Interim Chair of Board | less than a year | €793.97k | 0.061% € 565.3k | |
| Founder & Director | 10.3yrs | no data | 0.44% € 4.1m | |
| Member of Scientific Advisory Board | 6.5yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | €44.33k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 4.5yrs | €4.94k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | €35.24k | no data | |
| Independent Non-Executive Director | 6.8yrs | €135.16k | 0% € 0 | |
| Chairman of Scientific Advisory Board | 5.8yrs | no data | no data |
5.2yrs
Average Tenure
64yo
Average Age
Experienced Board: 2X1's board of directors are considered experienced (5.2 years average tenure).